Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade 4 vs 8 Cycles with ASCT in Myeloma
NCT00984828Phase 3Terminated
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Aug 2009
- Primary completion
- Jun 2016
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of bortezomib in multiple myeloma (MM), sponsored by Shanghai Jiao Tong University School of Medicine. Started Aug 2009; status: terminated.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00984828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00984828.